Authors
|
Year
|
Patients
|
Mean age, years (range)
|
AVN
|
Ratliff classification*
|
Ratliff assessment**
|
---|
I
|
II
|
III
|
Satisfied
|
Unsatisfied
|
---|
Stone et al. [5]
|
2015
|
22
|
11.0 (4.5–17.4)
|
8
|
5
|
2
|
1
|
3
|
5
|
Panigrahi et al. [6]
|
2015
|
28
|
10.5 (4–15)
|
4
|
0
|
2
|
2
|
NA
|
NA
|
Bukva et al. [7]
|
2015
|
28
|
10.7 (4–14)
|
11
|
6
|
3
|
2
|
NA
|
NA
|
Hadju et al. [8]
|
2011
|
8
|
11.6 (3–15)
|
1
|
0
|
1
|
0
|
NA
|
NA
|
Bali et al. [9]
|
2011
|
36
|
10.0 (3–16)
|
7
|
6
|
1
|
0
|
0
|
7
|
Nayeemuddin et al. [10]
|
2009
|
14
|
10.0 (6–14)
|
1
|
1
|
0
|
0
|
0
|
1
|
Inan et al. [11]
|
2009
|
39
|
11.1 (4–16)
|
11
|
8
|
1
|
2
|
1
|
10
|
Varshney et al. [12]
|
2009
|
21
|
11.8 (5–15)
|
3
|
1
|
2
|
0
|
NA
|
NA
|
Dhammi et al. [13]
|
2005
|
26
|
10.8 (3–17)
|
4
|
NA
|
NA
|
NA
|
0
|
4
|
Togrul et al. [14]
|
2005
|
61
|
10.2 (2–14)
|
9
|
8
|
1
|
0
|
NA
|
NA
|
Flynn et al. [15]
|
2002
|
18
|
8.0 (2–13)
|
1
|
0
|
1
|
0
|
NA
|
NA
|
Bagatur et al. [16]
|
2002
|
17
|
11.0 (7–14)
|
9
|
4
|
2
|
3
|
0
|
9
|
Mirdad et al. [17]
|
2002
|
14
|
9.1 (4–16)
|
7
|
4
|
3
|
0
|
NA
|
NA
|
Morsy et al. [18]
|
2001
|
53
|
10.2 (3–16)
|
21
|
NA
|
NA
|
NA
|
0
|
21
|
Ng et al. [19]
|
1996
|
32
|
9.5 (NA)
|
9
|
7
|
1
|
1
|
NA
|
NA
|
Forlin et al. [20]
|
1992
|
16
|
11.7 (4.6–16)
|
14
|
5
|
5
|
4
|
2
|
12
|
Canale et al. [21]
|
1977
|
60
|
9.7 (0.5–17)
|
26
|
21
|
1
|
4
|
1
|
25
|
Chong et al. [22]
|
1975
|
20
|
NA (5–19)
|
10
|
5
|
5
|
0
|
2
|
8
|
Zolczer et al. [23]
|
1972
|
27
|
NA (13–19)
|
7
|
2
|
5
|
0
|
5
|
2
|
Lam et al. [24]
|
1971
|
75
| NA (≦ 17) |
11
|
6
|
2
|
3
|
NA
|
NA
|
Ratliff [2]
|
1962
|
71
|
NA (< 17)
|
29
|
15
|
7
|
7
|
3
|
26
|
Total
| |
686
| |
203
|
104
|
45
|
29
|
17
|
130
|
Percentage
| | | |
29.6%
|
58.4%
|
25.3%
|
16.3%
|
11.6%
|
88.4%
|
- AVN avascular necrosis, NA missing value/not clear
- *Classification of avascular necrosis as proposed by Ratliff
- **Classification of final result according to Ratliff